Skip to main content
TDR: For Research on Diseases of Poverty

Access

  • Home Alt+0
  • Navigation Alt+1
  • Content Alt+2

Navigation

  • Home
  • About us
  • Research
  • Capacity building
  • Grants
  • Publications
    & resources
  • Partnerships
    & networks
  • Diseases
    & topics
  • News
    & events

Research on neglected priority needs, including product R&D, evaluation in real life settings, and increasing access to new tools

Developing research leadership through education, training, networks and quality management

Assessing global research needs and priorities, providing knowledge management and support for partner coordination

All the calls for research and training grants, career development fellowships and how to apply

Read, download or order TDR's publications and multimedia resources

For the latest news, press releases and TDR events

For more on TDR's strategy, governance, history and to find our staff

For more on TDR partnerships and networks

Search

Advanced search

Subnavigation

  • Research
  • Malaria research
    • Community case management of malaria
    • Integrated community case management of childhood illness
    • Rapid diagnostic tests
    • Rectal artesunate testing and delivery
    • Safety of drugs in pregnancy
  • Neglected tropical diseases research
    • Chagas
    • Dengue
    • African trypanosomiasis
    • Onchocerciasis
    • Visceral leishmaniasis
    • Schistosomiasis and soil-transmitted helminths
  • Tuberculosis and HIV research
    • Shortening and simplifying TB treatment
    • TB/HIV research
    • Improving TB diagnostics
    • Enhancing health systems
  • Vectors, environment and society research
    • New methods and strategies
    • Community-based interventions
    • Environmental climate change impact
    • Enhancing access to control
    • Capacity building

Onchocerciasis

Onchocerciasis is an eye and skin disease caused by the parasite Onchocerca volvulus. It causes intense itching and skin rashes, swelling and ultimately severe dermatitis, and damage in the eye can lead to impaired vision and ultimately blindness.

TDR has a long history of research to support the control of this disease, dating back to the partnership with the Onchocerciasis Control Programme that eliminated the mosquito that transmitted the disease in West Africa. TDR research with the African Programme for Onchocerciasis Control (APOC) has demonstrated how community-directed treatment with ivermectin (CDTI) is a sustainable and improved way of controlling the disease, and shows the possibility of eliminating transmission of the parasite.

Currently, research focuses on the identification of genetic markers of the parasite’s response to ivermectin and on evaluation of another compound, moxidectin, for its potential to accelerate elimination of onchocerciasis and expand the areas where elimination of transmission is feasible.

  • More on onchocerciasis
  • More on the history of TDR research on onchocerciasis
  • A new drug for onchocerciasis
  • Research profile of moxidectin at TDR
  • African Programme for Onchocerciasis Control (APOC)
  • The Mectizan Donation Program
  • Contact: Dr Annette Kuesel

Publications

  • Community-directed interventions for major health problems in Africa
  • Clinical trials of drugs for onchocerciasis: a randomised, single-ascending-dose, ivermectin-controlled, double-blind, safety, tolerability, pharmacokinetic, and efficacy study of orally administered moxidectin in subjects with onchocerca volvulus infection (Ghana)
  • Study Evaluating The Co-Administration Of Moxidectin And Midazolam In Healthy Subjects
  • Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin
  • Excretion of moxidectin into breast milk and pharmacokinetics in healthy lactating women
  • The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans
  • Research for control: the onchocerciasis experience

Latest news

  • New series on helminth infections R&D agenda
  • Dengue control support through eco-bio-social approach
  • A call for closer ties to communities
  • Pipeline grows for neglected diseases research and development (R&D)
  • VL elimination by 2015 on track with new research
  • Onchocerciasis can be eliminated with ivermectin
  • VL rapid diagnostics may be inadequate in Brazil and East Africa

Related links

  • African clinical trial site capacity available for other research
    pdf, 1.40Mb
  • Health Research Policy and Systems journal article: Empowering communities in combating river blindness
    May 2012

You are here:

  • TDR
  • Research
  • Neglected tropical disease (NTD) research
  • Onchocerciasis
  • © WHO 2013
  • More about our sponsors
  • Contact us

Special Programme for Research and Training in Tropical Diseases (TDR)